MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2

Biochemical and Biophysical Research Communications

Volumn 436, Issue 4, 2013, Pages 578-584

  Yang, Tao ^a   Zhang, Guo fei ^a   Chen, Xiao fan ^a   Gu, Hai hua ^a   Fu, Shao zi ^a   Xu, Hong feng ^a   Feng, Qiang ^a   Ni, Yi Ming ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cardiac hypertrophy; EZH2; MiR 214; MiRNAs

Indexed keywords

MICRORNA 214; TRANSCRIPTION FACTOR EZH2;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DOWN REGULATION; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION; WESTERN BLOTTING;

ACTA1; ACTIN ALPHA 1; BETA-MYOSIN HEAVY-CHAIN GENE; CARDIAC HYPERTROPHY; ENHANCER OF ZESTE HOMOLOG 2; EZH2; LENTI-MIR-214; LENTI-SPG; LENTIVIRUS-MIR-214; LENTIVIRUS-MIR-214 SPONGE; MICRORNA-214; MIR-214; MIRNAS; MYH7; NATRIURETIC PEPTIDE A; NPPA; POLYCOMB REPRESSOR COMPLEX 2; PRC2; SINE OCULIS HOMEOBOX HOMOLOG 1; SIX1; UNTRANSLATED REGION; UTR;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CARDIOMEGALY; HEK293 CELLS; HUMANS; MALE; MICRORNAS; POLYCOMB REPRESSIVE COMPLEX 2; RATS; RATS, SPRAGUE-DAWLEY; SEQUENCE HOMOLOGY, NUCLEIC ACID; SIGNAL TRANSDUCTION;

LENTIVIRUS; RATTUS;

EID: 84880045471     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.079     Document Type: Article

References (42)

1. Fiedler J., Thum T. MicroRNAs in Myocardial Infarction. Arterios. Thromb. Vas. Biol. 2013, 33(2):201-205.
2. Y.R. Fujii, The xenotropic microRNA gene information for stem cell researches and clinical applications (2013).
3. Kathirvel P., Ramesh Kumar G., Sankaranarayanan K. A computational prediction of conserved microRNA targets of ion channels in vertebrates. Curr. Bioinform. 2013, 8(1):93-111.
4. Vincenzo L., Ventura C. Regenerative medicine approach to repair the failing heart. Vas. pharmacol. 2013.
5. Roche P., Czubryt M.P., Wigle J.T. Molecular mechanisms of cardiac development. Car. Adapt. 2013, 19-39.
6. Shijun L., Ding'an M. MicroRNAs and cardiovascular disease. Int. J. Pathol. Clin. Med. 2011, 6:017.
7. Stauffer B.L., Russell G., Nunley K., Miyamoto S.D., Sucharov C.C. MiRNA expression in pediatric failing human heart. J. Mol. Cell. Cardiol. 2013.
8. Vacchi-Suzzi C., Hahne F., Scheubel P., Marcellin M., Dubost V., Westphal M., Boeglen C., Büchmann-Møller S., Cheung M.S., Cordier A. Heart structure-specific transcriptomic atlas reveals conserved microRNA-mRNA interactions. PLoS One 2013, 8(1):e52442.
9. Ryu S., McDonnell K., Choi H., Gao D., Hahn M., Joshi N., Park S., Catena R., Do Y., Brazin J. Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration. Cancer Cell 2013, 23(1):63.
10. Delgado-Olguín P., Huang Y., Li X., Christodoulou D., Seidman C.E., Seidman J., Tarakhovsky A., Bruneau B.G. Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. Nat. Gene. 2012.
11. Di Stefano V., Zaccagnini G., Capogrossi M.C., Martelli F. MicroRNAs as peripheral blood biomarkers of cardiovascular disease. Vas. Pharmacol. 2011, 55(4):111-118.
12. Kinoshita T., Nohata N., Fuse M., Hanazawa T., Kikkawa N., Fujimura L., Takano H., Yamada Y., Yoshino H., Enokida H. Tumor suppressive microRNA-133a/ regulates novel targets Moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma. Biochem. Biophys. Res. Commun. 2012.
13. Chen J.F., Murchison E.P., Tang R., Callis T.E., Tatsuguchi M., Deng Z., Rojas M., Hammond S.M., Schneider M.D., Selzman C.H. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc. Natl. Acad. Sci. 2008, 105(6):2111-2116.
14. Care A., Catalucci D., Felicetti F., Bonci D., Addario A., Gallo P., Bang M.L., Segnalini P., Gu Y., Dalton N.D. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 2007, 13(5):613-618.
15. Drawnel F.M., Wachten D., Molkentin J.D., Maillet M., Aronsen J.M., Swift F., Sjaastad I., Liu N., Catalucci D., Mikoshiba K. Mutual antagonism between IP3RII and miRNA-133a regulates calcium signals and cardiac hypertrophy. J. General Physiol. 2013, 141(1):i1.
16. Duisters R.F., Tijsen A.J., Schroen B., Leenders J.J., Lentink V., van der Made I., Herias V., van Leeuwen R.E., Schellings M.W., Barenbrug P. MiR-133 and miR-30 regulate connective tissue growth factor implications for a role of microRNAs in myocardial matrix remodeling. Circul. Res. 2009, 104(2):170-178.
17. Feng B., Chen S., George B., Feng Q., Chakrabarti S. MiR133a regulates cardiomyocyte hypertrophy in diabetes. Diab./Metab. Res. Rev. 2010, 26(1):40-49.
18. Horie T., Ono K., Nishi H., Iwanaga Y., Nagao K., Kinoshita M., Kuwabara Y., Takanabe R., Hasegawa K., Kita T. MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes. Biochem. Biophys. Res. Commun. 2009, 389(2):315-320.
19. Li Q., Lin X., Yang X., Chang J. NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression. Am. J. Physiol.-Heart Circul. Physiol. 2010, 298(5):H1340-H1347.
20. van Rooij E., Quiat D., Johnson B.A., Sutherland L.B., Qi X., Richardson J.A., Kelm R.J., Olson E.N. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Develop. Cell 2009, 17(5):662-673.
21. van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Sci. Signal. 2007, 316(5824):575.
22. Tatsuguchi M., Seok H.Y., Callis T.E., Thomson J.M., Chen J.F., Newman M., Rojas M., Hammond S.M., Wang D.Z. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol. 2007, 42(6):1137-1141.
23. Cheng Y., Ji R., Yue J., Yang J., Liu X., Chen H., Dean D.B., Zhang C. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?. Am. J. Pathol. 2007, 170(6):1831.
24. Costa da Martins P.A., Bourajjaj M., Gladka M., Kortland M., van Oort R.J., Pinto Y.M., Molkentin J.D., De Windt L.J. Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 2008, 118(15):1567-1576.
25. Van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., Richardson J.A., Olson E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. 2006, 103(48):18255-18260.
26. Pan W., Zhong Y., Cheng C., Liu B., Wang L., Li A., Xiong L., Liu S. MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy. PLoS One 2013, 8(1):e53950.
27. Yang Y., Ago T., Zhai P., Abdellatif M., Sadoshima J. Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7 novelty and significance. Circul. Res. 2011, 108(3):305-313.
28. Wang J., Song Y., Zhang Y., Xiao H., Sun Q., Hou N., Guo S., Wang Y., Fan K., Zhan D. Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res. 2011, 22(3):516-527.
29. Lin Z., Murtaza I., Wang K., Jiao J., Gao J., Li P.F. MiR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc. Natl. Acad. Sci. 2009, 106(29):12103-12108.
30. Townley-Tilson W., Callis T.E., Wang D.Z. MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. Int. J. Biochem. Cell Biol. 2010, 42(8):1252-1255.
31. Varrone F., Gargano B., Carullo P., Di Silvestre D., De Palma A., Grasso L., Di Somma C., Mauri P., Benazzi L., Franzone A. The circulating level of FABP3 is an indirect biomarker of microRNA-1. J. Am. College Cardiol. 2013, 61(1):88-95.
32. Wang J., Xu R., Lin F., Zhang S., Zhang G., Hu S., Zheng Z. MicroRNA: novel regulators involved in the remodeling and reverse remodeling of the heart. Cardiology 2009, 113(2):81-88.
33. Song J., Lee M., Kim D., Han J., Chun C., Jin E. MicroRNA-181b regulates articular chondrocytes differentiation and cartilage integrity. Biochem. Biophys. Res. Commun. 2013.
34. Funahashi H., Izawa H., Hirashiki A., Cheng X.W., Inden Y., Nomura M., Murohara T. Altered microRNA expression associated with reduced catecholamine sensitivity in patients with chronic heart failure. J. Cardiol. 2011, 57(3):338-344.
35. Ikeda S., Kong S.W., Lu J., Bisping E., Zhang H., Allen P.D., Golub T.R., Pieske B., Pu W.T. Altered microRNA expression in human heart disease. Physiol. Gen. 2007, 31(3):367-373.
36. Li S., Zhu J., Zhang W., Chen Y., Zhang K., Popescu L.M., Ma X., Lau W.B., Rong R., Yu X. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection clinical perspective. Circulation 2011, 124(2):175-184.
37. Sayed D., Hong C., Chen I.Y., Lypowy J., Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circul. Res. 2007, 100(3):416-424.
38. Soci U.P.R., Fernandes T., Hashimoto N.Y., Mota G.F., Amadeu M.A., Rosa K.T., Irigoyen M.C., Phillips M.I., Oliveira E.M. MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats. Physiol. Gen. 2011, 43(11):665-673.
39. Thum T., Catalucci D., Bauersachs J. MicroRNAs: novel regulators in cardiac development and disease. Cardiovas. Res. 2008, 79(4):562-570.
40. Wilson K.D., Hu S., Venkatasubrahmanyam S., Fu J.D., Sun N., Abilez O.J., Baugh J.J.A., Jia F., Ghosh Z., Li R.A. Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells clinical perspective role for miR-499. Circul. Cardiovas. Gene. 2010, 3(5):426-435.
41. Yang K.C., Ku Y.C., Lovett M., Nerbonne J.M. Combined deep microRNA and mRNA sequencing identifies protective transcriptomal signature of enhanced PI3Kα signaling in cardiac hypertrophy. J. Mol. Cell. Cardiol. 2012.
42. Juan A.H., Kumar R.M., Marx J.G., Young R.A., Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol. Cell 2009, 36(1):61-74.